Mayelana-umdlavuza / ukwelashwa / izidakamizwa / isibindi

Izidakamizwa zivunyelwe umdlavuza wesibindi

Leli khasi libala izidakamizwa zomdlavuza ezivunyelwe yi-Food and Drug Administration (FDA) ngomdlavuza wesibindi. Uhlu lufaka amagama ejwayelekile namagama ezimpawu. Amagama ezidakamizwa axhumanisa nezifinyezo ze-Cancer Information Information ze-NCI. Kungaba nezidakamizwa ezisetshenziswa kumdlavuza wesibindi ezingabhalisiwe lapha.

Izidakamizwa zivunyelwe umdlavuza wesibindi

I-Cabometyx (Cabozantinib-S-Malate)

ICabozantinib-S-Malate

ICyramza (iRamucirumab)

I-Keytruda (Pembrolizumab)

Lenvatinib Mesylate

I-Lenvima (Lenvatinib Mesylate)

I-Nexavar (iSorafenib Tosylate)

UNivolumab

I-Opdivo (Nivolumab)

I-Pembrolizumab

URamucirumab

Regorafenib

ISorafenib Tosylate

I-Stivarga (Regorafenib)